Unilever

Unilever

Unilever was formed in 1929 when Lever Brothers, the British soapmaker behind Sunlight and Lifebuoy, merged with the Dutch margarine producer Margarine Unie. The logic was built on shared raw-material inputs — palm oil and fats served both businesses. Today the group employs roughly 128,000 people (per the firm, 2023) and sells in more than 190 countries. Its dual-listed structure ended in 2020 when Unilever unified under a single UK parent, a governance shift that simplified a decades-old Anglo-Dutch arrangement. Unilever Ventures operates as the group's in-house venture-capital arm, investing from a permanently allocated balance-sheet fund rather than raising outside LP capital. The unit targets early-stage businesses in personal care, digital platforms, and food-tech, with a geographic remit spanning Europe, North America, and India. Confirmed portfolio investments include Nutrafol, the ingestible-hair-health brand sold to Unilever in a majority deal; True Botanicals, a prestige clean-beauty line; and mocktail brand Mockingbird Spirit. In addition to direct venture deals, Unilever Ventures participates in fund commitments and has co-invested alongside outside GPs such as Fireside Ventures in India. Unilever's corporate art collections and real-estate holdings form a parallel asset base separate from the venture arm. These include Unilever House on London's Victoria Embankment, the Netherlands Unilever Art Collection in The Hague, and commercial property in Rotterdam and Mumbai. The venture unit itself operates from London, with Unilever Ventures registered as a member of the British Venture Capital Association. The family trusts of co-founder William Hesketh Lever were fully bought out by Unilever in 2014 for $1.2 billion, severing the last formal link to the founding Lever dynasty (per The Guardian, 2014). A structural differentiator for Unilever Ventures is its permanent-capital base: because it invests corporate balance-sheet money rather than third-party LP funds, it has no fixed fundraising cycle and can hold positions indefinitely. That architecture enables follow-on participation and patient capital deployment that fund-life-constrained VCs often cannot match. The unit also serves as an innovation-sensing function for a global consumer-goods machine that spends roughly €6.7 billion annually on brand and marketing investment (per the firm, 2023), giving portfolio companies a potential pathway to scaled commercial validation inside Unilever's own distribution channels.